GlassScriptPhysician profile
Ammar Alqaid
NPI 1235484692
$17,811.38
in general payments reported to CMS, 2019-2025
29 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $257 · 2021: $391 · 2022: $7,676 · 2023: $4,693 · 2024: $1,922 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,625 · Food and Beverage: $2,733 · Travel and Lodging: $1,583 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,625.00 |
| Food and Beverage | $2,733.40 |
| Travel and Lodging | $1,582.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,041.38 | 2022-2025 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,138.39 | 2019-2025 | Ofev |
| Medtronic, INC. | $963.06 | 2023 | Illumisite |
| Body Vision Medical INC. | $860.35 | 2024 | Lungvision |
| Actelion Pharmaceuticals US, INC. | $473.33 | 2019-2021 | |
| Galvanize Therapeutics, INC | $312.11 | 2023-2025 | Aliya System |
| Astrazeneca Pharmaceuticals LP | $283.44 | 2019-2025 | Tezspire, Breztri |
| Glaxosmithkline, LLC. | $230.70 | 2019-2025 | Nucala |
| Janssen Pharmaceuticals, INC | $203.56 | 2019-2021 | |
| Veran Medical Technologies, INC. | $175.46 | 2019 | |
| Mallinckrodt Hospital Products INC. | $145.23 | 2025 | Terlivaz |
| Grifols USA, LLC | $123.18 | 2025 | Prolastin-C Liquid |
| Insmed, INC. | $114.98 | 2019 | |
| Pulmonx Corporation | $114.75 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Merck Sharp & Dohme LLC | $90.42 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $83.98 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $75.59 | 2019-2021 | |
| Pfizer INC. | $73.01 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $70.67 | 2025 | Dupixent |
| Baxter Healthcare | $42.68 | 2021 | |
| Gilead Sciences, INC. | $30.62 | 2019 | |
| Verona Pharma, INC. | $25.67 | 2025 | Ohtuvayre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.83 | 2019 | |
| Genentech USA, INC. | $23.96 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.30 | 2021 | |
| Sandoz INC. | $22.19 | 2019 | |
| Shionogi INC | $17.66 | 2020 | |
| Philips North America LLC | $16.54 | 2025 | Vest Therapy Und |
| Shire North American Group INC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Alqaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.